Anita Dushyanth
Stock Analyst at Berenberg
(2.58)
# 2,168
Out of 5,138 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $18.80 | +6.38% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.66 | +255.19% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.84 | +65,117.39% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $19.16 | +385.39% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $18.80
Upside: +6.38%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.66
Upside: +255.19%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.84
Upside: +65,117.39%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $19.16
Upside: +385.39%